Chlorprothixene
Chlorprothixene is a first-generation antipsychotic medication belonging to the thioxanthene class, used primarily to treat psychotic disorders such as schizophrenia and, in some settings, acute mania associated with bipolar disorder. It works mainly by blocking dopamine receptors in the brain, helping reduce psychotic symptoms, agitation and related behavioural disturbances. It is generally administered orally in tablet form, depending on local availability and prescribing guidance. Common side effects include drowsiness, dizziness, dry mouth, constipation, weight gain and low blood pressure. Important risks include abnormal involuntary movements, heart-rhythm disturbances and neuroleptic malignant syndrome, a rare but serious reaction. Treatment should be supervised by a healthcare professional; alcohol and other sedating medicines may increase drowsiness.
Chlorprothixene was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Chlorprothixene, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Chlorprothixene from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Chlorprothixene, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
